mastomi
natalensi
rat
increas
west
africa
dri
season
rat
like
insid
individu
hous
fluctuat
climat
result
increas
crop
yield
associ
rat
popul
follow
sever
drought
lead
increas
case
lassa
fever
furthermor
climact
chang
alter
vectorborn
infecti
diseas
risk
due
expand
vector
rang
exampl
increas
risk
lyme
diseas
canada
due
tick
rang
expans
climat
chang
expand
mosquito
rang
associ
infecti
diseas
risk
aed
albopictu
unit
state
rna
virus
repres
signific
sourc
viral
outbreak
due
partli
higher
mutat
rate
error
prone
natur
rna
replic
newli
introduc
mutat
viral
genom
confer
new
pathogen
characterist
enabl
transmiss
new
speci
increas
virul
instanc
mutat
within
sever
acut
respiratori
syndrom
coronaviru
sarscov
genom
allow
transmiss
bat
human
better
understand
viral
agent
respons
caus
outbreak
human
underli
factor
drive
emerg
better
chanc
prepared
effect
intervent
prevent
new
global
epidem
fig
chapter
provid
overview
genom
precis
medicin
methodolog
relev
topic
emerg
reemerg
viral
threat
chapter
divid
two
main
section
viral
genom
host
genom
includ
exampl
applic
pathogen
detect
popul
suscept
diagnost
outbreak
respons
semin
investig
transmiss
yellow
fever
viru
walter
reed
colleagu
usher
era
discoveri
classif
wide
varieti
viral
pathogen
includ
smallpox
viru
polioviru
measl
viru
technolog
advanc
includ
viral
cell
cultur
plaqu
assay
enzymelink
immunosorb
assay
monoclon
antibodi
push
human
virolog
forward
second
wave
viral
discoveri
character
current
ongo
harvest
power
nextgener
sequenc
identifi
unknown
virus
acut
febril
ill
patient
increasingli
effort
underway
identifi
next
emerg
pathogen
sequenc
identifi
virus
circul
humananimalpathogen
interfac
detect
virus
wildlif
predict
transmiss
identifi
mutat
gene
acquisit
surveil
continu
discoveri
provid
valuabl
insight
futur
major
hindranc
precis
medicin
toward
emerg
zoonot
pathogen
limit
global
character
potenti
threat
taxonom
placement
virus
problemat
due
lack
univers
gene
bacteri
rna
gene
limit
classif
virus
defin
biolog
characterist
fact
mere
total
speci
current
classifi
intern
committe
taxonomi
virus
ictv
pale
comparison
estim
viral
speci
infect
mammal
alon
metagenom
sequenc
highlight
signific
gap
classifi
vs
unknown
virom
biolog
character
also
alway
defin
knowledg
gain
genom
sequenc
includ
evolutionari
relationship
genom
structur
continu
gather
viral
genom
inform
environment
plant
anim
sampl
continu
fill
gap
knowledg
base
prepar
us
detect
predict
emerg
pathogen
metagenom
sequenc
use
discoveri
previous
unclassifi
human
pathogen
lujo
viru
discov
south
africa
sequenc
divers
lassa
viru
complic
molecular
diagnost
tool
develop
phylogenet
tree
gener
use
align
full
length
near
full
length
lassa
viru
segment
nucleic
acid
sequenc
avail
genbank
divers
lassa
viru
link
geograph
locat
shown
virus
sequenc
nigeria
sierra
leon
guinea
mali
togo
select
sequenc
countri
star
align
b
forward
revers
primer
red
arrow
probe
green
arrow
previous
publish
lassa
viru
josiah
realtim
rtpcr
assay
indic
primer
probe
exact
match
lassa
viru
josiah
sequenc
howev
contain
mismatch
within
lassa
viru
isol
includ
one
found
sierra
leon
five
patient
undiagnos
hemorrhag
fever
discov
air
transfer
critic
ill
index
case
diseas
result
case
fatal
rate
unbias
pyrosequenc
rna
extract
human
sampl
identifi
approxim
arenaviru
genom
thereaft
gap
fill
use
primer
design
sequenc
genom
phylogenet
analysi
confirm
identif
novel
old
world
arenaviru
similarli
deep
sequenc
identifi
bascongo
viru
novel
rhabdoviru
three
human
case
democrat
republ
congo
viru
associ
high
fever
rapid
death
found
aminoacid
ident
rhabdovirus
discoveri
character
virus
allow
novel
diagnost
develop
includ
realtim
pcr
lead
better
prepared
futur
outbreak
sequenc
human
sampl
outbreak
result
discoveri
sever
virus
howev
emerg
human
pathogen
result
wildlif
analysi
sampl
nonhuman
host
includ
arthropod
bat
rodent
domest
anim
offer
potenti
insight
transmiss
evolut
treatment
pathogen
deep
sequenc
invertebr
speci
result
discoveri
phylogenet
distinct
virom
fill
phylogenet
evolutionari
gap
character
bacteri
viral
relationship
mosquito
arthropod
demonstr
symbiot
relationship
bacterium
host
limit
dengu
viru
infect
potenti
reveal
new
antivir
strategi
discoveri
middleeast
respiratori
syndromecoronaviru
merscov
camel
demonstr
anim
potenti
reservoir
host
transmiss
detect
virus
wildlif
predict
transmiss
identifi
mutat
gene
acquisit
surveil
continu
discoveri
provid
valuabl
insight
futur
addit
pathogen
discoveri
metagenom
sequenc
increasingli
use
monitor
viral
genom
chang
outbreak
occur
ebola
viru
outbreak
west
africa
result
case
document
death
genom
sequenc
appli
near
realtim
provid
inform
aid
contain
outbreak
sequenc
result
earli
outbreak
provid
valuabl
insight
origin
transmiss
rout
demonstr
outbreak
start
singl
introduct
guinea
decemb
sustain
human
human
transmiss
sequenc
provid
molecular
evid
ebola
viru
transmiss
sexual
intercours
lead
chang
cdc
recommend
survivor
establish
program
support
nation
test
semen
bodi
fluid
male
survivor
rapid
outbreak
sequenc
allow
identif
transmiss
chain
sporad
cluster
follow
outbreak
ad
insight
end
epidem
sequenc
data
sierra
leon
earli
outbreak
also
found
increas
ebola
viru
divers
could
impact
sequencebas
therapeut
vaccin
diagnost
assay
field
time
rapid
sequenc
inform
outbreak
would
inform
respond
potenti
efficaci
diagnost
sequencebas
countermeasur
either
reassur
decis
maker
inform
need
modifi
strategi
base
find
sequenc
found
nich
discoveri
epidemiolog
trace
emerg
infect
roll
diagnost
still
infanc
emerg
pathogen
often
occur
auster
environ
countri
limit
infrastructur
conduc
sequenc
technolog
sequenc
still
signific
hurdl
decreas
technic
mechan
requir
routin
clinic
use
howev
nextgener
sequenc
offer
limitless
potenti
due
necess
littl
prior
knowledg
sampl
composit
newer
technolog
nanopor
sequenc
look
minim
hurdl
creat
smaller
footprint
near
realtim
sequenc
analysi
minim
sampl
prepar
howev
difficult
path
accept
beyond
laboratori
deriv
test
full
regulatori
approv
remain
knowledg
viral
genom
sequenc
design
rapid
point
care
molecular
diagnost
pcr
invalu
last
decad
seen
signific
increas
use
pcr
primari
diagnost
due
speed
sensit
cost
howev
due
lack
avail
genom
sequenc
high
genet
variat
within
certain
viral
speci
find
conserv
target
difficult
advent
multiplex
pcr
allow
target
captur
singl
assay
lower
cost
increas
throughput
exampl
techniqu
use
subtyp
influenza
b
virus
diagnost
devic
biofir
filmarray
run
multipl
pcr
singl
devic
allow
user
select
differ
panel
whether
singleplex
multiplex
pcr
remain
rapid
sensit
method
detect
viral
genom
directli
clinic
matric
coordin
detect
viral
genom
sequenc
increasingli
use
predict
guid
antivir
therapi
ebola
viru
outbreak
sequenc
analysi
viral
genom
time
demonstr
chang
could
make
pathogen
resist
therapeut
sirna
phosphorodiamid
morpholino
oligom
pmo
antibodi
discoveri
system
abil
destroy
dsdna
brought
light
potenti
mutat
essenti
site
remov
provir
dna
infect
cell
hiv
infect
crispr
similarli
studi
involv
herpesvirus
larg
dsdna
virus
demonstr
abil
destroy
latent
herpesviru
infect
cell
method
requir
prior
knowledg
viral
genom
promis
futur
antivir
therapi
target
specif
toward
individu
specif
infect
emerg
reemerg
viral
diseas
pose
uniqu
challeng
use
omic
precis
medicin
tool
one
predict
pathogen
jump
speci
barrier
emerg
new
popul
could
rapidli
spread
new
geograph
region
complic
scenario
new
human
viral
infect
may
present
obviou
sign
infect
viru
may
get
introduc
transmit
across
popul
remain
asymptomat
unrecogn
long
period
time
like
hepat
c
viru
hcv
hiv
instanc
virus
reli
smallsiz
genom
encod
enough
inform
hijack
host
cellular
machineri
targetcel
recognit
entri
genom
replic
protein
synthesi
viral
participl
assembl
propag
evolutionarili
host
evolv
conserv
mechan
gener
immun
respons
detect
limit
infect
prevent
reinfect
futur
earli
innat
immun
respons
function
slow
infect
immun
system
recogn
infect
extens
review
guid
subsequ
adapt
immun
respons
pathogen
success
control
immunolog
process
depend
tight
control
host
immunolog
inflammatori
pathway
regul
gene
transcript
process
result
measur
chang
rel
express
level
code
noncod
rna
protein
even
infect
asymptomat
difficult
diagnos
develop
lowcost
lesstim
consum
genom
facilit
studi
pathwayspecif
transcript
alter
viral
infect
consequ
variou
transcriptomicbas
assay
develop
studi
character
identifi
sign
infect
use
transcript
signatur
exampl
zaa
colleagu
identifi
uniqu
immunolog
gene
express
profil
capabl
differenti
viral
bacteri
respiratori
infect
human
lay
foundat
appropri
antibiot
use
without
direct
pathogen
identif
tradit
diagnos
viral
infect
made
base
clinic
symptom
pcr
serolog
test
viru
isol
world
omic
expand
new
improv
platform
host
transcriptomebas
assay
becom
feasibl
wide
avail
relev
chapter
target
agnost
nextgener
sequenc
ng
platform
genomewid
associ
studi
gwa
transcriptom
well
microarraybas
assay
amplificationindepend
profil
transcript
gwa
direct
applic
precis
medicin
wherea
hostbas
transcriptom
assay
shown
multipl
applic
clinic
diagnosi
pathogen
identif
character
technolog
specif
develop
emerg
reemerg
virus
leverag
purpos
base
applic
gwa
may
provid
insight
genet
factor
drive
popul
suscept
viral
infect
inform
util
identifi
popul
within
geograph
region
higher
lower
risk
infect
new
pathogen
higherrisk
popul
may
includ
increas
direct
exposur
anim
reservoir
zoonot
pathogen
arthropod
vector
popul
subgroup
without
defin
topograph
relationship
determin
well
exampl
demograph
age
gender
group
classifi
base
genet
polymorph
suscept
marker
set
gwa
provid
guidanc
outbreak
prepared
intervent
inform
provid
gwasbas
studi
focus
direct
respons
infect
inform
alreadi
store
within
host
genom
hand
transcriptom
approach
identifi
interact
pathogen
host
genom
evalu
transcript
level
typic
mrna
commonli
use
transcriptom
method
rnaseq
microarray
rnaseq
gener
suitabl
unbias
transcriptom
profil
provid
better
understand
global
transcriptom
chang
agnost
method
appropri
identifi
chang
human
transcriptom
result
emerg
viral
infect
show
specif
mechan
immun
respons
evas
effect
host
biolog
transcriptom
level
convers
targetedapproach
depend
previou
knowledg
hosttranscriptom
studi
human
cohort
anim
model
develop
gene
signatur
discrimin
viral
bacteri
respiratori
infect
group
develop
sepsi
classifi
guid
treatment
option
clinic
set
goal
develop
diseas
classifi
use
predict
diseas
outcom
prior
onset
symptom
assist
decis
make
symptomat
diseas
unknown
etiolog
suspect
effect
accur
discern
viral
bacteri
infect
make
differ
administ
appropri
therapeut
potenti
save
live
specif
viral
speci
ca
nt
identifi
gene
classifi
may
use
determin
potenti
diseas
outcom
lethal
technolog
continu
advanc
linkag
genom
precis
medicin
emerg
infecti
diseas
continu
strengthen
improv
sequenc
accuraci
speed
push
pathogenspecif
genom
near
realtim
allow
rapid
access
critic
inform
within
timefram
impact
outbreak
respons
confid
result
sequenc
lead
clinic
action
diagnost
patient
test
reason
forese
rapid
pathogen
agnost
diagnost
assay
routin
util
clinic
popul
growth
expans
rural
geograph
region
rapid
travel
greatli
expand
pathogenhostenviron
interactom
put
greater
number
peopl
risk
formerli
exot
infecti
diseas
ebola
viru
even
next
unknown
soontoemerg
pathogen
appli
genom
host
transcriptom
gener
respons
viral
bacteri
pathogen
would
allow
appropri
antibiot
use
without
requir
direct
pathogen
detect
besid
benefit
antibiot
stewardship
era
antimicrobi
resist
expand
rapidli
applic
greatli
improv
clinic
care
event
emerg
highli
virul
unknown
unknown
organ
opinion
interpret
conclus
recommend
author
necessarili
endors
us
armi
